OOIR: Observatory of International Research

Papers

(The H4-Index of Molecular Pharmaceutics is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
The Uniqueness of Albumin as a Carrier in Nanodrug Delivery	197
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies	189
Engineered Human Adipose Stem-Cell-Derived Exosomes Loaded with miR-21-5p to Promote Diabetic Cutaneous Wound Healing	108
Nanomedicine-Based Approaches for mRNA Delivery	82
Nanomedicine in Healing Chronic Wounds: Opportunities and Challenges	79
Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition	72
Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood–Brain Barrier for Effective Treatment of Alzheimer’s Disease	69
Intranasal Delivery and Transfection of mRNA Therapeutics in the Brain Using Cationic Liposomes	68
Nanoparticle-Based Drug Delivery System: The Magic Bullet for the Treatment of Chronic Pulmonary Diseases	65
Lipid-Based Nanoparticles for Delivery of Vaccine Adjuvants and Antigens: Toward Multicomponent Vaccines	63
In Vitro and In Vivo Comparison of Curcumin-Encapsulated Chitosan-Coated Poly(lactic-co-glycolic acid) Nanoparticles and Curcumin/Hydroxypropyl-β-Cyclodextrin Inclusion Complexes	61
Recent Advances in Microfluidics for the Preparation of Drug and Gene Delivery Systems	61
Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components	57
Development of Hydrogels with Self-Healing Properties for Delivery of Bioactive Agents	56
Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs	56
Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer’s Disease, Parkinson’s Disease, and Intracerebral Hemorrhage	55
Characterization of Differential Tissue Abundance of Major Non-CYP Enzymes in Human	54
Tumor-Associated Macrophages Promote Oxaliplatin Resistance via METTL3-Mediated m⁶A of TRAF5 and Necroptosis in Colorectal Cancer	53
Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI)	53
Electrospun PVP-Core/PHBV-Shell Fibers to Eliminate Tailing Off for an Improved Sustained Release of Curcumin	52
Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer	51
Dissipative Particle Dynamics Aided Design of Drug Delivery Systems: A Review	50
Emerging Nano Drug Delivery Systems Targeting Cancer-Associated Fibroblasts for Improved Antitumor Effect and Tumor Drug Penetration	48
Potential Roles of the Glass Transition Temperature of PLGA Microparticles in Drug Release Kinetics	44
Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection	44

MTX-Loaded Dual Thermoresponsive and pH-Responsive Magnetic Hydrogel Nanocomposite Particles for Combined Controlled Drug Delivery and Hyperthermia Therapy of Cancer	44
Combination Therapy of Doxorubicin and Quercetin on Multidrug-Resistant Breast Cancer and Their Sequential Delivery by Reduction-Sensitive Hyaluronic Acid-Based Conjugate/d-α-Tocopheryl Pol	43
Comparison of Absolute Protein Abundances of Transporters and Receptors among Blood–Brain Barriers at Different Cerebral Regions and the Blood–Spinal Cord Barrier in Humans and Rats	42
Current Status and Future Perspectives on MRNA Drug Manufacturing	42
Ligand-Modified Erythrocyte Membrane-Cloaked Metal–Organic Framework Nanoparticles for Targeted Antitumor Therapy	41
Mesenchymal Stem Cell-Derived Exosomes Loaded with miR-155 Inhibitor Ameliorate Diabetic Wound Healing	41
Recent Advances in Co-processed APIs and Proposals for Enabling Commercialization of These Transformative Technologies	41
Bilirubin Nanomedicines for the Treatment of Reactive Oxygen Species (ROS)-Mediated Diseases	41
Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity	41
Synergistic Chemotherapy for Breast Cancer and Breast Cancer Brain Metastases via Paclitaxel-Loaded Oleanolic Acid Nanoparticles	41
Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells	40
EGFR-Targeted Nanobody Functionalized Polymeric Micelles Loaded with mTHPC for Selective Photodynamic Therapy	40
Machine Learning Applied to Determine the Molecular Descriptors Responsible for the Viscosity Behavior of Concentrated Therapeutic Antibodies	39
Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug–Polymer Interactions	39